Company intelligence / Profile preview

EnvisionTEC

Dearborn, Michigan, United States

Ownership: Private
Employees: ~193
Development stage: Other

Overview

EnvisionTEC pioneered high-resolution, medical- and dental-grade 3D printers, including bioprinters capable of printing tissue scaffolds and clinical tools; its COVID-19 swab design passed IRB-approved trials and was successfully commercialized. The dental product line includes FDA 510(k)-cleared, CE-marked, and MDR Class I-certified materials such as Flexcera.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceBioprinting platformMedical devicePolymer 3D printerBiofabrication
Industry: Therapeutic Medical Devices

Partnerships

Desktop MetalSprintRayBeth Israel Deaconess Medical Center

Beyond the preview

Go deeper on EnvisionTEC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnvisionTEC.

Explore the full profile